Targeting ATF6 reduces pathological neovascularization and improves visual outcomes in retinal disease models

Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by E...

Full description

Saved in:

Bibliographic Details
Published in:	Scientific reports Vol. 15; no. 1; pp. 33070 - 15
Main Authors:	Bradley, Allyssa, Park, Soyoung, Park, Soyeon, Kim, Kyle, Galdamez, Angela, Min, Hyejung, Diaz-Aguilar, Monica Sophia, Hartnett, M. Elizabeth, Lee, Eun-Jin, Lin, Jonathan H.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 26.09.2025 Nature Publishing Group Nature Portfolio
Subjects:	631/136/16 631/378/2613/1786 692/699/3161/3175 692/699/3161/3175/3188 Activating transcription factor 6 Activating Transcription Factor 6 - antagonists & inhibitors Activating Transcription Factor 6 - genetics Activating Transcription Factor 6 - metabolism Age Angiogenesis Animals Blood vessels Cell Proliferation Diabetes mellitus Disease Models, Animal Endothelial cells Humanities and Social Sciences Hyperoxia Hypoxia Hypoxia-inducible factor 1a Kinases Macular degeneration Mice Mice, Inbred C57BL Mice, Knockout multidisciplinary Physiology Postpartum period Protein folding Proteins Retina Retina - metabolism Retina - pathology Retinal Neovascularization - genetics Retinal Neovascularization - metabolism Retinal Neovascularization - pathology Retinopathy Retinopathy of Prematurity - metabolism Retinopathy of Prematurity - pathology Science Science (multidisciplinary) Signal Transduction Therapeutic targets Unfolded Protein Response - genetics Vascular endothelial growth factor Vascularization Vision Visual perception
ISSN:	2045-2322, 2045-2322
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 −/− mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 −/− mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6’s causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases.
AbstractList	Abstract Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 −/− mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 −/− mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6’s causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases. Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 −/− mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 −/− mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6’s causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases. Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6−/− mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6−/− mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6’s causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases. Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6's causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases. Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6-/- mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6-/- mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6's causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases.Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6-/- mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6-/- mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6's causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases. Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration (AMD), and diabetic retinopathy. The Unfolded Protein Response (UPR) is an intracellular signal transduction mechanism that is activated by ER stress and upregulates many proteins, including angiogenesis factors like VEGF and HIF-1α. This suggests that UPR genes and pathways may drive retinal angiogenesis. Here, we tested the role of the UPR regulator Activating Transcription Factor 6 (ATF6) in pathological and developmental retinal angiogenesis. We induced pathological retinal neovascularization in Atf6 −/− mice using the oxygen-induced retinopathy (OIR) model and found significantly preserved visual function, accompanied by decreased retinal neovascularization, endothelial cell proliferation, and UPR transcriptional program induction. When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, we also saw suppressed retinal expression of UPR genes. Additionally, in postnatal day 7 Atf6 −/− mice when the retinal vasculature is developing in response to physiologic intraocular hypoxia, there was a transient but significant defect in pruning and retinal blood vessel extension. Together, our results demonstrate ATF6’s causal role in developmental and pathological retinal angiogenesis and highlight its potential as a therapeutic target to preserve vision in retinal neovascularization diseases.
ArticleNumber	33070
Author	Hartnett, M. Elizabeth Kim, Kyle Lee, Eun-Jin Diaz-Aguilar, Monica Sophia Galdamez, Angela Bradley, Allyssa Park, Soyeon Lin, Jonathan H. Min, Hyejung Park, Soyoung
Author_xml	– sequence: 1 givenname: Allyssa surname: Bradley fullname: Bradley, Allyssa organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 2 givenname: Soyoung surname: Park fullname: Park, Soyoung organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 3 givenname: Soyeon surname: Park fullname: Park, Soyeon organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University – sequence: 4 givenname: Kyle surname: Kim fullname: Kim, Kyle organization: Department of Pathology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 5 givenname: Angela surname: Galdamez fullname: Galdamez, Angela organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 6 givenname: Hyejung surname: Min fullname: Min, Hyejung organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 7 givenname: Monica Sophia surname: Diaz-Aguilar fullname: Diaz-Aguilar, Monica Sophia organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration, Rush Medical College, Rush University – sequence: 8 givenname: M. Elizabeth surname: Hartnett fullname: Hartnett, M. Elizabeth organization: Department of Ophthalmology, School of Medicine, Stanford University – sequence: 9 givenname: Eun-Jin surname: Lee fullname: Lee, Eun-Jin organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration – sequence: 10 givenname: Jonathan H. surname: Lin fullname: Lin, Jonathan H. email: Jonathan.H.Lin@stanford.edu organization: Department of Pathology, School of Medicine, Stanford University, Department of Ophthalmology, School of Medicine, Stanford University, VA Palo Alto Health Care System, Department of Veterans Affairs, Veterans Health Administration, School of Medicine, Stanford University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/41006433$$D View this record in MEDLINE/PubMed
BookMark	eNp9kcFu1DAQhi1URNulL8ABReLCJWB7nMQ5VhWFSpW4LGfLa0-CV0m82MlKy9MzNKVFHPDFntE3_3jmv2RnU5yQsTeCfxAc9MesRNXqksuqFBW0UJ5esAvJVVVKkPLsr_c5u8p5z-lUslWifcXOleC8VgAXbNza1OMcpr643t7WRUK_OMzFwc7f4xD74OxQTBiPNrtlsCn8tHOIU2EnX4TxkOKR4GPIC2FxmV0cKQ4T6ZAm5XzIaDMWY_Q45NfsZWeHjFeP94Z9u_20vflS3n_9fHdzfV86BXoudSMUSvACwSqlZIsKGi98rTk0nd3tlLdCdg3SiL7R0DjHfeNrTrkKvIINu1t1fbR7c0hhtOlkog3mIRFTb2yagxvQVC0A1G3La2qq0VPIGy06i7vO6RpJ6_2qRcP-WDDPZgzZ4TBYWsuSDchKtZI0OKHv_kH3cUm0hpXSSgCBG_b2kVp2I_qn7_0xhQC5Ai7FnBN2T4jg5rf5ZjXfkPnmwXxzoiJYizLBU4_pufd_qn4BhfWw4g
Cites_doi	10.1126/science.1209038 10.1158/1541-7786.MCR-06-0150 10.1111/jnc.13714 10.1038/sj.emboj.7600777 10.1016/j.bbadis.2013.03.010 10.1016/j.immuni.2004.06.010 10.1186/1471-2105-12-323 10.1038/ncb2738 10.1161/CIRCRESAHA.116.310266 10.1016/j.devcel.2007.07.005 10.1002/cne.22530 10.1016/j.cell.2009.03.025 10.1167/iovs.06-0016 10.1016/S1350-9462(01)00012-X 10.1016/j.aquaculture.2024.741926 10.1038/s41598-021-95895-7 10.1016/j.biocel.2012.03.004 10.1038/s41598-019-40135-2 10.1016/j.preteyeres.2023.101231 10.1016/j.metabol.2012.01.004 10.1083/jcb.200302047 10.1007/s10456-007-9065-1 10.1126/scisignal.aan5785 10.1016/j.preteyeres.2014.12.001 10.1128/MCB.23.21.7448-7459.2003 10.1038/sj.emboj.7600030 10.1186/s13059-014-0550-8 10.1172/JCI175562 10.1074/jbc.M609490200 10.1074/jbc.M113.507194 10.1242/jcs.045625 10.1021/acschembio.9b00134 10.1038/nature05571 10.1016/j.semcdb.2007.09.003 10.1038/nm1591 10.1167/iovs.12-11492 10.1007/82_2017_36 10.1371/journal.pgen.1004335 10.1016/S1097-2765(03)00105-9 10.1001/archopht.119.4.499 10.1056/NEJMra1208129 10.1371/journal.pone.0060517 10.1073/pnas.2103196118 10.1038/ng.3319 10.1016/j.preteyeres.2017.11.001 10.3390/biom10060895 10.1007/978-3-031-76550-6_53 10.1038/nprot.2009.187 10.1111/jnc.12981 10.1172/JCI200521848 10.1002/ijc.2910310104 10.1167/iovs.10-5176 10.3345/cep.2021.00773 10.2119/molmed.2010.00070 10.1371/journal.pone.0009575 10.1016/j.cmet.2015.07.010 10.1186/1471-213X-9-72 10.1111/micc.12752 10.1007/s40123-023-00744-7 10.7554/eLife.11878 10.1101/cshperspect.a006569 10.1128/MCB.22.21.7405-7416.2002 10.1016/j.ophtha.2014.07.050 10.1002/pmic.200400983 10.1038/nature04482 10.1016/j.febslet.2009.04.007 10.1371/journal.pone.0032167 10.1146/annurev-vision-093022-021420 10.1111/dmcn.15468 10.1136/archdischild-2016-310532 10.1038/eye.1993.61 10.1387/ijdb.041895ms 10.1080/02713683.2018.1542736 10.1039/c3ib40085a 10.1167/iovs.64.11.17 10.1007/s10633-009-9198-1 10.1016/S1097-2765(01)00264-7 10.1101/gad.14.2.152 10.1128/MCB.22.11.3864-3874.2002 10.1200/JCO.2023.41.16_suppl.1092 10.1016/j.ajpath.2019.11.009 10.1016/j.ajpath.2012.12.020 10.1200/JCO.2024.42.16_suppl.e15118 10.1016/j.ajpath.2022.12.002 10.1016/j.molcel.2014.03.022 10.1038/srep16752 10.1158/0008-5472.CAN-06-3235
ContentType	Journal Article
Copyright	This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025 – notice: 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 DOA
DOI	10.1038/s41598-025-15393-y
DatabaseName	Springer Nature Open Access Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest - Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
EndPage	15
ExternalDocumentID	oai_doaj_org_article_59333699067148ed9330781faebfc86e 41006433 10_1038_s41598_025_15393_y
Genre	Journal Article
GrantInformation_xml	– fundername: U.S. Department of Veterans Affairs grantid: Merit I01BX002284 funderid: https://doi.org/10.13039/100000738 – fundername: National Institutes of Health grantid: P30EY026877 funderid: https://doi.org/10.13039/100000002 – fundername: California Institute for Regenerative Medicine grantid: DISC2-10973 funderid: https://doi.org/10.13039/100000900 – fundername: NEI NIH HHS grantid: P30 EY026877 – fundername: NIH HHS grantid: P30EY026877 – fundername: BLRD VA grantid: I01 BX002284 – fundername: U.S. Department of Veterans Affairs grantid: Merit I01BX002284 – fundername: California Institute for Regenerative Medicine grantid: DISC2-10973
GroupedDBID	0R~ 4.4 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AASML ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M1P M2P M7P M~E NAO OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RNT RNTTT RPM SNYQT UKHRP AAYXX AFFHD CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 88A 8FK K9. M48 PKEHL PQEST PQUKI PRINS Q9U 7X8
ID	FETCH-LOGICAL-c438t-8714e23d1e3a44429e437d1d68037fabb4da12f7e045d7837cc0d7d602f753d43
IEDL.DBID	DOA
ISICitedReferencesCount	0
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001582541100030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2045-2322
IngestDate	Fri Oct 03 12:53:20 EDT 2025 Sat Sep 27 17:45:50 EDT 2025 Tue Oct 07 09:20:17 EDT 2025 Wed Oct 01 06:56:57 EDT 2025 Sat Nov 29 07:29:15 EST 2025 Sat Sep 27 01:10:37 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c438t-8714e23d1e3a44429e437d1d68037fabb4da12f7e045d7837cc0d7d602f753d43
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://doaj.org/article/59333699067148ed9330781faebfc86e
PMID	41006433
PQID	3254841323
PQPubID	2041939
PageCount	15
ParticipantIDs	doaj_primary_oai_doaj_org_article_59333699067148ed9330781faebfc86e proquest_miscellaneous_3254923360 proquest_journals_3254841323 pubmed_primary_41006433 crossref_primary_10_1038_s41598_025_15393_y springer_journals_10_1038_s41598_025_15393_y
PublicationCentury	2000
PublicationDate	2025-09-26
PublicationDateYYYYMMDD	2025-09-26
PublicationDate_xml	– month: 09 year: 2025 text: 2025-09-26 day: 26
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationTitleAlternate	Sci Rep
PublicationYear	2025
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	J Han (15393_CR53) 2013; 15 K Liu (15393_CR78) 2006; 47 M Bi (15393_CR21) 2005; 24 15393_CR7 F Milde (15393_CR62) 2013; 5 S Nakamura (15393_CR32) 2013; 8 J Wu (15393_CR35) 2007; 13 EJ Lee (15393_CR37) 2025; 135 KA Vessey (15393_CR81) 2011; 519 A Galdamez (15393_CR28) 2025; 1468 R Blanco (15393_CR65) 2013; 3 HM Ta (15393_CR43) 2016; 139 J Gerdes (15393_CR91) 1983; 31 JM Provis (15393_CR1) 2001; 20 MF Rimawi (15393_CR86) 2023; 41 M Fruttiger (15393_CR6) 2007; 10 15393_CR72 ME Hartnett (15393_CR10) 2012; 367 A Papaioannou (15393_CR17) 2017 E Karali (15393_CR15) 2014; 54 15393_CR33 AH Lee (15393_CR56) 2003; 23 O Dembinska (15393_CR77) 2002; 43 MI Love (15393_CR90) 2014; 15 E Engelbrecht (15393_CR93) 2022; 29 DL Howarth (15393_CR40) 2014; 10 SX Zhang (15393_CR18) 2015; 45 C Koumenis (15393_CR20) 2002; 22 JK Jin (15393_CR41) 2017; 120 R Sriburi (15393_CR59) 2007; 282 KM Connor (15393_CR14) 2009; 4 B Li (15393_CR89) 2011; 12 R Rust (15393_CR94) 2019; 9 LEH Smith (15393_CR44) 1994; 35 JMD Grandjean (15393_CR88) 2019; 14 T Chan-Ling (15393_CR4) 1995; 36 L Liu (15393_CR24) 2015; 8 EH Hong (15393_CR12) 2022; 65 R Benedito (15393_CR64) 2009; 137 15393_CR63 V Nikolova-Krstevski (15393_CR92) 2009; 9 A Stahl (15393_CR5) 2010; 51 C Koumenis (15393_CR22) 2006; 4 15393_CR61 BT Soetikno (15393_CR85) 2015; 5 Z Pawlowska (15393_CR67) 2005; 5 L Liu (15393_CR23) 2013; 182 Y Wan (15393_CR26) 2025; 597 M Usui (15393_CR39) 2012; 61 J Li (15393_CR51) 2009; 583 HP Harding (15393_CR74) 2001; 7 AL Solebo (15393_CR8) 2017; 102 ME Hartnett (15393_CR13) 2015; 122 ER Pereira (15393_CR30) 2014; 289 HP Harding (15393_CR54) 2003; 11 P Zhang (15393_CR75) 2002; 22 A Yoshikawa (15393_CR42) 2015; 132 VH Guaiquil (15393_CR47) 2013; 54 AB Fulton (15393_CR80) 2001; 119 ME Hartnett (15393_CR9) 2023; 15 15393_CR19 P Walter (15393_CR69) 2011; 334 A Salminen (15393_CR31) 2010; 16 PD Lu (15393_CR57) 2004; 23 AZ Dudek (15393_CR87) 2024; 42 A Moszyńska (15393_CR71) 2020; 10 OJ Mezu-Ndubuisi (15393_CR46) 2020; 26 O Dammann (15393_CR11) 2023; 65 OJ Mezu-Ndubuisi (15393_CR45) 2018; 44 R Ghosh (15393_CR29) 2010; 5 F Binet (15393_CR16) 2015; 22 15393_CR55 ME Hartnett (15393_CR50) 2023; 12 KM Connor (15393_CR49) 2007; 13 M Hellström (15393_CR66) 2007; 445 RM Hansen (15393_CR79) 2000; 41 S Nakamura (15393_CR82) 2012; 7 Y Nakamura (15393_CR25) 2013; 1832 S Shi (15393_CR34) 2023; 64 S Kohl (15393_CR38) 2015; 47 X Reynaud (15393_CR76) 1995; 36 EJ Lee (15393_CR60) 2023; 193 Z Jian (15393_CR27) 2012; 44 EJ Lee (15393_CR36) 2021; 11 JD Malhotra (15393_CR68) 2007; 18 M Saint-Geniez (15393_CR2) 2004; 48 B Drogat (15393_CR70) 2007; 67 AL Shaffer (15393_CR58) 2004; 21 S Selvam (15393_CR3) 2018; 63 K Zhang (15393_CR73) 2005; 115 15393_CR83 JV Forrester (15393_CR48) 1993; 7 H Bommiasamy (15393_CR52) 2009; 122 JD Akula (15393_CR84) 2010; 120
References_xml	– volume: 334 start-page: 1081 year: 2011 ident: 15393_CR69 publication-title: Science doi: 10.1126/science.1209038 – volume: 4 start-page: 423 year: 2006 ident: 15393_CR22 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-06-0150 – volume: 36 start-page: 1201 year: 1995 ident: 15393_CR4 publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 139 start-page: 1124 year: 2016 ident: 15393_CR43 publication-title: J. Neurochem doi: 10.1111/jnc.13714 – volume: 24 start-page: 3470 year: 2005 ident: 15393_CR21 publication-title: EMBO J. doi: 10.1038/sj.emboj.7600777 – volume: 1832 start-page: 1117 year: 2013 ident: 15393_CR25 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2013.03.010 – volume: 21 start-page: 81 year: 2004 ident: 15393_CR58 publication-title: Immunity doi: 10.1016/j.immuni.2004.06.010 – volume: 12 start-page: 323 year: 2011 ident: 15393_CR89 publication-title: BMC Bioinform. doi: 10.1186/1471-2105-12-323 – volume: 15 start-page: 481 year: 2013 ident: 15393_CR53 publication-title: Nat. Cell. Biol. doi: 10.1038/ncb2738 – volume: 8 start-page: 6960 year: 2015 ident: 15393_CR24 publication-title: J. Clin. Exp. Pathol. – volume: 120 start-page: 82 year: 2017 ident: 15393_CR41 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.310266 – volume: 13 start-page: 351 year: 2007 ident: 15393_CR35 publication-title: Dev. Cell. doi: 10.1016/j.devcel.2007.07.005 – volume: 519 start-page: 506 year: 2011 ident: 15393_CR81 publication-title: J. Comp. Neurol. doi: 10.1002/cne.22530 – volume: 137 start-page: 1124 year: 2009 ident: 15393_CR64 publication-title: Cell doi: 10.1016/j.cell.2009.03.025 – volume: 47 start-page: 2639 year: 2006 ident: 15393_CR78 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.06-0016 – volume: 20 start-page: 799 year: 2001 ident: 15393_CR1 publication-title: Prog Retin Eye Res. doi: 10.1016/S1350-9462(01)00012-X – volume: 43 start-page: 2481 year: 2002 ident: 15393_CR77 publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 597 start-page: 741926 year: 2025 ident: 15393_CR26 publication-title: Aquaculture doi: 10.1016/j.aquaculture.2024.741926 – volume: 11 start-page: 16356 year: 2021 ident: 15393_CR36 publication-title: Sci. Rep. doi: 10.1038/s41598-021-95895-7 – volume: 44 start-page: 972 year: 2012 ident: 15393_CR27 publication-title: Int. J. Biochem. Cell. Biol. doi: 10.1016/j.biocel.2012.03.004 – volume: 9 start-page: 3263 year: 2019 ident: 15393_CR94 publication-title: Sci. Rep. doi: 10.1038/s41598-019-40135-2 – ident: 15393_CR19 doi: 10.1016/j.preteyeres.2023.101231 – volume: 61 start-page: 1118 year: 2012 ident: 15393_CR39 publication-title: Metabolism doi: 10.1016/j.metabol.2012.01.004 – ident: 15393_CR63 doi: 10.1083/jcb.200302047 – volume: 10 start-page: 77 year: 2007 ident: 15393_CR6 publication-title: Angiogenesis doi: 10.1007/s10456-007-9065-1 – ident: 15393_CR33 doi: 10.1126/scisignal.aan5785 – volume: 45 start-page: 111 year: 2015 ident: 15393_CR18 publication-title: Prog Retin Eye Res. doi: 10.1016/j.preteyeres.2014.12.001 – volume: 23 start-page: 7448 year: 2003 ident: 15393_CR56 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.23.21.7448-7459.2003 – volume: 23 start-page: 169 year: 2004 ident: 15393_CR57 publication-title: EMBO J. doi: 10.1038/sj.emboj.7600030 – volume: 15 start-page: 550 year: 2014 ident: 15393_CR90 publication-title: Genome Biol. doi: 10.1186/s13059-014-0550-8 – volume: 135 start-page: e175562 year: 2025 ident: 15393_CR37 publication-title: J. Clin. Invest. doi: 10.1172/JCI175562 – volume: 282 start-page: 7024 year: 2007 ident: 15393_CR59 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M609490200 – volume: 289 start-page: 3352 year: 2014 ident: 15393_CR30 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.507194 – volume: 122 start-page: 1626 year: 2009 ident: 15393_CR52 publication-title: J. Cell. Sci. doi: 10.1242/jcs.045625 – volume: 26 start-page: 257 year: 2020 ident: 15393_CR46 publication-title: Mol. Vis. – volume: 14 start-page: 784 year: 2019 ident: 15393_CR88 publication-title: ACS Chem. Biol. doi: 10.1021/acschembio.9b00134 – volume: 445 start-page: 776 year: 2007 ident: 15393_CR66 publication-title: Nature doi: 10.1038/nature05571 – volume: 18 start-page: 716 year: 2007 ident: 15393_CR68 publication-title: Semin Cell. Dev. Biol. doi: 10.1016/j.semcdb.2007.09.003 – volume: 13 start-page: 868 year: 2007 ident: 15393_CR49 publication-title: Nat. Med. doi: 10.1038/nm1591 – volume: 35 start-page: 101 year: 1994 ident: 15393_CR44 publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 54 start-page: 5294 year: 2013 ident: 15393_CR47 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.12-11492 – start-page: 159 volume-title: Coordinating Organismal Physiology Through the Unfolded Protein Response year: 2017 ident: 15393_CR17 doi: 10.1007/82_2017_36 – volume: 10 start-page: e1004335 year: 2014 ident: 15393_CR40 publication-title: PLOS Genet. doi: 10.1371/journal.pgen.1004335 – volume: 11 start-page: 619 year: 2003 ident: 15393_CR54 publication-title: Mol. Cell. doi: 10.1016/S1097-2765(03)00105-9 – volume: 119 start-page: 499 year: 2001 ident: 15393_CR80 publication-title: Arch. Ophthalmol. doi: 10.1001/archopht.119.4.499 – volume: 367 start-page: 2515 year: 2012 ident: 15393_CR10 publication-title: N Engl. J. Med. doi: 10.1056/NEJMra1208129 – volume: 8 start-page: e60517 year: 2013 ident: 15393_CR32 publication-title: PLOS ONE doi: 10.1371/journal.pone.0060517 – ident: 15393_CR55 doi: 10.1073/pnas.2103196118 – volume: 47 start-page: 757 year: 2015 ident: 15393_CR38 publication-title: Nat. Genet. doi: 10.1038/ng.3319 – volume: 63 start-page: 1 year: 2018 ident: 15393_CR3 publication-title: Prog Retin Eye Res. doi: 10.1016/j.preteyeres.2017.11.001 – volume: 10 start-page: 895 year: 2020 ident: 15393_CR71 publication-title: Biomolecules doi: 10.3390/biom10060895 – volume: 1468 start-page: 319 year: 2025 ident: 15393_CR28 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-3-031-76550-6_53 – volume: 4 start-page: 1565 year: 2009 ident: 15393_CR14 publication-title: Nat. Protoc. doi: 10.1038/nprot.2009.187 – volume: 132 start-page: 342 year: 2015 ident: 15393_CR42 publication-title: J. Neurochem doi: 10.1111/jnc.12981 – volume: 115 start-page: 268 year: 2005 ident: 15393_CR73 publication-title: J. Clin. Invest. doi: 10.1172/JCI200521848 – volume: 31 start-page: 13 year: 1983 ident: 15393_CR91 publication-title: Int. J. Cancer doi: 10.1002/ijc.2910310104 – volume: 51 start-page: 2813 year: 2010 ident: 15393_CR5 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.10-5176 – volume: 65 start-page: 115 year: 2022 ident: 15393_CR12 publication-title: Clin. Exp. Pediatr. doi: 10.3345/cep.2021.00773 – volume: 16 start-page: 535 year: 2010 ident: 15393_CR31 publication-title: Mol. Med. doi: 10.2119/molmed.2010.00070 – volume: 5 start-page: e9575 year: 2010 ident: 15393_CR29 publication-title: PLOS ONE doi: 10.1371/journal.pone.0009575 – volume: 22 start-page: 560 year: 2015 ident: 15393_CR16 publication-title: Cell. Metab. doi: 10.1016/j.cmet.2015.07.010 – volume: 9 start-page: 72 year: 2009 ident: 15393_CR92 publication-title: BMC Dev. Biol. doi: 10.1186/1471-213X-9-72 – volume: 29 start-page: e12752 year: 2022 ident: 15393_CR93 publication-title: Microcirculation doi: 10.1111/micc.12752 – volume: 12 start-page: 2241 year: 2023 ident: 15393_CR50 publication-title: Ophthalmol. Ther. doi: 10.1007/s40123-023-00744-7 – ident: 15393_CR61 doi: 10.7554/eLife.11878 – volume: 3 start-page: a006569 year: 2013 ident: 15393_CR65 publication-title: Cold Spring Harb Perspect. Med. doi: 10.1101/cshperspect.a006569 – volume: 22 start-page: 7405 year: 2002 ident: 15393_CR20 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.22.21.7405-7416.2002 – volume: 36 start-page: 1071 year: 1995 ident: 15393_CR76 publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 122 start-page: 200 year: 2015 ident: 15393_CR13 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.07.050 – volume: 5 start-page: 1217 year: 2005 ident: 15393_CR67 publication-title: Proteomics doi: 10.1002/pmic.200400983 – ident: 15393_CR7 doi: 10.1038/nature04482 – volume: 583 start-page: 1521 year: 2009 ident: 15393_CR51 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2009.04.007 – volume: 7 start-page: e32167 year: 2012 ident: 15393_CR82 publication-title: PLOS ONE doi: 10.1371/journal.pone.0032167 – volume: 15 start-page: 39 year: 2023 ident: 15393_CR9 publication-title: Annu. Rev. Vis. Sci. doi: 10.1146/annurev-vision-093022-021420 – volume: 65 start-page: 625 year: 2023 ident: 15393_CR11 publication-title: Dev. Med. Child. Neurol. doi: 10.1111/dmcn.15468 – volume: 41 start-page: 320 year: 2000 ident: 15393_CR79 publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 102 start-page: 853 year: 2017 ident: 15393_CR8 publication-title: Arch. Dis. Child. doi: 10.1136/archdischild-2016-310532 – volume: 7 start-page: 276 year: 1993 ident: 15393_CR48 publication-title: Eye doi: 10.1038/eye.1993.61 – volume: 48 start-page: 1045 year: 2004 ident: 15393_CR2 publication-title: Int. J. Dev. Biol. doi: 10.1387/ijdb.041895ms – volume: 44 start-page: 275 year: 2018 ident: 15393_CR45 publication-title: Curr. Eye Res. doi: 10.1080/02713683.2018.1542736 – volume: 5 start-page: 1426 year: 2013 ident: 15393_CR62 publication-title: Integr. Biol. Camb. doi: 10.1039/c3ib40085a – volume: 64 start-page: 17 year: 2023 ident: 15393_CR34 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.64.11.17 – volume: 120 start-page: 41 year: 2010 ident: 15393_CR84 publication-title: Doc. Ophthalmol. doi: 10.1007/s10633-009-9198-1 – volume: 7 start-page: 1153 year: 2001 ident: 15393_CR74 publication-title: Mol. Cell. doi: 10.1016/S1097-2765(01)00264-7 – ident: 15393_CR72 doi: 10.1101/gad.14.2.152 – volume: 22 start-page: 3864 year: 2002 ident: 15393_CR75 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.22.11.3864-3874.2002 – volume: 41 start-page: 1092 year: 2023 ident: 15393_CR86 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2023.41.16_suppl.1092 – ident: 15393_CR83 doi: 10.1016/j.ajpath.2019.11.009 – volume: 182 start-page: 1412 year: 2013 ident: 15393_CR23 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2012.12.020 – volume: 42 start-page: e15118 year: 2024 ident: 15393_CR87 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2024.42.16_suppl.e15118 – volume: 193 start-page: 1721 year: 2023 ident: 15393_CR60 publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2022.12.002 – volume: 54 start-page: 559 year: 2014 ident: 15393_CR15 publication-title: Mol. Cell. doi: 10.1016/j.molcel.2014.03.022 – volume: 5 start-page: 16752 year: 2015 ident: 15393_CR85 publication-title: Sci. Rep. doi: 10.1038/srep16752 – volume: 67 start-page: 6700 year: 2007 ident: 15393_CR70 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3235
SSID	ssj0000529419
Score	2.4607499
Snippet	Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular degeneration... Abstract Pathological retinal neovascularization is a cause of vision loss in diseases including retinopathy of prematurity (ROP), wet age-related macular...
SourceID	doaj proquest pubmed crossref springer
SourceType	Open Website Aggregation Database Index Database Publisher
StartPage	33070
SubjectTerms	631/136/16 631/378/2613/1786 692/699/3161/3175 692/699/3161/3175/3188 Activating transcription factor 6 Activating Transcription Factor 6 - antagonists & inhibitors Activating Transcription Factor 6 - genetics Activating Transcription Factor 6 - metabolism Age Angiogenesis Animals Blood vessels Cell Proliferation Diabetes mellitus Disease Models, Animal Endothelial cells Humanities and Social Sciences Hyperoxia Hypoxia Hypoxia-inducible factor 1a Kinases Macular degeneration Mice Mice, Inbred C57BL Mice, Knockout multidisciplinary Physiology Postpartum period Protein folding Proteins Retina Retina - metabolism Retina - pathology Retinal Neovascularization - genetics Retinal Neovascularization - metabolism Retinal Neovascularization - pathology Retinopathy Retinopathy of Prematurity - metabolism Retinopathy of Prematurity - pathology Science Science (multidisciplinary) Signal Transduction Therapeutic targets Unfolded Protein Response - genetics Vascular endothelial growth factor Vascularization Vision Visual perception
SummonAdditionalLinks	– databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwcARbkLjwhgYKMhI3iGpnvLFzQi3qigNaVWiRerOytoP20GzZ7Fbav-_YcVIhHheOcSbJOON5eMYzA_C-EN7rJYYzVZrnslAV8RxW-ZQ75LbAytvYteSrms_1xUV1nhxuXTpWOcjEKKjd2gYf-THSTkaTxC3w09XPPHSNCtHV1ELjLhyESmVyAgenZ_Pzb6OXJcSxpKhStgxHfdyRxgpZZcU0J2avMN__opFi4f4_WZu_RUqjApo9-l_UH8PDZHqyk36tPIE7vn0K9_tmlPtncLmIh8Lp2-xkMSvZJhR19R0LPYsHCclaP55dTQmcrG4dW0XXBAFfr7odga13W0KNrlctC2mS4bspFMRi753uOXyfnS0-f8lTM4bcStRboqCQvkAnPNZSkhbzEpUTrtQcVVMvl9LVomiUJxvRKdr2WsudciWnsSk6iS9g0q5bfwjMel2R4WTJGqkl0o5PcqyVaNCqJoiEDD4MBDFXfc0NE2PlqE1PPkPkM5F8Zp_BaaDZCBnqZceB9eaHSexnphUilqR5S5qG9i64cZQWTe2XjdWlz-BoIJ1JTNyZW7pl8G68TewXYio1_fBdD0M2MpY8g5f9ShkxkSIafPT0x2Hp3L787xN69W9cXsODIqzeEBkrj2Cy3ez8G7hnr7erbvM2McANk1kL7A priority: 102 providerName: ProQuest
Title	Targeting ATF6 reduces pathological neovascularization and improves visual outcomes in retinal disease models
URI	https://link.springer.com/article/10.1038/s41598-025-15393-y https://www.ncbi.nlm.nih.gov/pubmed/41006433 https://www.proquest.com/docview/3254841323 https://www.proquest.com/docview/3254923360 https://doaj.org/article/59333699067148ed9330781faebfc86e
Volume	15
WOSCitedRecordID	wos001582541100030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest - Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1db9Mw8AQbSLyg8R3YKiPxBtFinxs7j9u0akisilCRypOV2o7UBzLUtJP67znbaRkCxAsvluLYsX3n893lzncA7wT3Xi8w-FTpIpdCVURzWOXjwmFhBVbexqwln9R0qufzqr6T6iv4hKXwwAlwp2PSuLGkM7NUJLl7FxRwpXnb-EVrdenD6UvD3FGmUlRvUUleDbdkCtSnPXGqcJtMjHMi8grz7S-cKAbs_5OU-ZuFNDKeyRE8HiRGdpZm-gTu-e4pPEw5JLfP4Nss-nJTV3Y2m5RsFWKx-p6FVMO7g411fu9yOty7ZE3n2DL-UaDGt8t-Q81uNmvagPS87Fi43RjGHSw4LKbM6Z_Dl8nl7OIqH3Io5FaiXhPgufQCHffYSEnMx0tUjrtSF6jaZrGQruGiVZ5EO6dIW7W2cMqVBdWN0Ul8AQfdTedfAbNeVyTvWBIiGomkqMkCG8VbtKoNlJzB-x08zfcUKsNEEzdqk6BvCPomQt9sMzgPIN-3DGGuYwUh3wzIN_9CfgbHO4SZgfZ6g6TzauLNAjN4u39NVBNMIQ0BfJPakGiLZZHBy4To_Uwkj3Ia9f6ww_zPj_99Qa__x4LewCMRtmgwe5XHcLBebfwJPLC362W_GsF9NVex1CM4PL-c1p9Hcd9TeS3qUCoqD-uP1_XXH7tqAsM
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAoILzwKBAkaCE0RNPN7YOSBUHqtWXVYcFmlvJms71R7Ils1u0f6p_saOnUeFeNx64JjETmzn8-cZz4wH4CVPnVMz9D5VKokFlznNOczjQWIxMRxzZ0LWkpEcj9V0mn_ZgrMuFsa7VXacGIjaLozfI99D0mQUMS7Hdyc_Yp81yltXuxQaDSyO3OYnqWz128OP9H9fcT78NPlwELdZBWIjUK2oKalwHG3qsBCC6NgJlDa1mUpQlsVsJmyR8lI6EnasJP3NmMRKmyV0b4BWIL33ClylitK7kMmp7Pd0vNVMpHkbm5Og2qtpffQxbHwQE7XkGG9-Wf9CmoA_yba_2WXDcje8_b8N1B241QrWbL-ZCXdhy1X34HqTanNzH75Pgss79ZXtT4YZW_oja13NfEbmjv9Z5XrP3DY8lRWVZfOw8UKFT-f1moot1isaCrqeV8wHgfrvtoYuFjIL1Tvw9VL6-gC2q0XlHgEzTuUkFhqStQqBpM-KBAuZlmhk6QkvgtcdAPRJc6KIDp4AqHQDF01w0QEuehPBe4-RvqQ_DTzcWCyPdUsuepAjYkZyRUbdUM76TSqp0rJws9KozEWw20FFtxRV6wucRPCif0zk4i1GBQ34uilDGgBmSQQPG2T2LRFpEGep9psOqhcv_3uHHv-7Lc_hxsHk80iPDsdHT-Am9zPH2wCzXdheLdfuKVwzp6t5vXwWph6Db5cN4XM3AmYG
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAhUX3o9AASPBCaJNPE7sHBAqlBVVy2oPi9Sbm7UdtIdmy2a3aP8av46xk2yFeNx64LhZJ7Gdbz7PeGY8AC956pyaoo-pUkksuCxI5rCIs8RiYjgWzoSqJUdyNFLHx8V4C370uTA-rLLnxEDUdm78HvkAyZJRxLgcB1UXFjHeH747-xb7ClLe09qX02ghcujW38l8a94e7NO3fsX58OPkw6e4qzAQG4FqSd1KheNoU4elEETNTqC0qc1VgrIqp1Nhy5RX0pHiYyXZcsYkVto8oWsZWoH03CtwVYos89L1mY83-zvegybSosvTSVANGlorfT4bz2KimQLj9S9rYSgZ8Cc99zcfbVj6hrf-50m7DTc7hZvttRJyB7ZcfReutyU41_fgdBJC4WncbG8yzNnCH2XrGuYrNffrAqvdJmK3S1tlZW3ZLGzIUOPzWbOiZvPVkqaFfs9q5pND_Xs7BxgLFYea-_DlUsb6ALbree0eATNOFaQuGtLBSoFk54oES5lWaGTliTCC1z0Y9Fl70ogOEQKodAsdTdDRATp6HcF7j5dNS39KeLgwX3zVHenorEDEnPSNnIahnPWbV1KlVemmlVG5i2C3h43uqKvRF5iJ4MXmbyId70kqacJXbRuyDDBPInjYonTTE5EGNZfuftPD9uLhfx_Q43_35TnsEHL10cHo8Anc4F6IvGsw34Xt5WLlnsI1c76cNYtnQQoZnFw2gn8CrqVu0w
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+ATF6+reduces+pathological+neovascularization+and+improves+visual+outcomes+in+retinal+disease+models&rft.jtitle=Scientific+reports&rft.au=Bradley%2C+Allyssa&rft.au=Park%2C+Soyoung&rft.au=Park%2C+Soyeon&rft.au=Kim%2C+Kyle&rft.date=2025-09-26&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft.spage=33070&rft_id=info:doi/10.1038%2Fs41598-025-15393-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon